Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mari Anno"'
Autor:
Tsuyoshi Okura, Risa Nakamura, Sonoko Kitao, Yuichi Ito, Mari Anno, Kazuhisa Matsumoto, Kyoko Shoji, Kazuhiko Matsuzawa, Shoichiro Izawa, Hiroko Okura, Etsuko Ueta, Masahiko Kato, Takeshi Imamura, Shin-ichi Taniguchi, Kazuhiro Yamamoto
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-8 (2023)
Abstract Background Hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes mellitus (T2DM). HIC was reported to decrease in patients with type 2 diabetes and metabolic syndrome. HIC is originally calculated by post-load in
Externí odkaz:
https://doaj.org/article/1ce58db6bd4649d7ba32035c154b891c
Autor:
Tsuyoshi Okura, Risa Nakamura, Mari Anno, Yuichi Ito, Sonoko Kitao, Satomi Endo, Natsuka Taneda, Kazuhisa Matsumoto, Kyoko Shoji, Hiroko Okura, Kazuhiko Matsuzawa, Shoichiro Izawa, Etsuko Ueta, Masahiko Kato, Takeshi Imamura, Shin-ichi Taniguchi, Kazuhiro Yamamoto
Publikováno v:
Metabolism Open, Vol 18, Iss , Pp 100242- (2023)
Background: Aldehyde dehydrogenase 2 (ALDH2) is an important enzyme involved in alcohol metabolism. ALDH2 polymorphism has been reported as a risk factor for type 2 diabetes mellitus (T2DM) and is associated with liver insulin resistance due to alcoh
Externí odkaz:
https://doaj.org/article/8211d21397754963a39e77a1d23277a9
Autor:
Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Yuichi Ito, Sonoko Kitao, Mari Anno, Kazuhisa Matsumoto, Kyoko Shoji, Hiroko Okura, Kazuhiko Matsuzawa, Shoichiro Izawa, Etsuko Ueta, Masahiko Kato, Takeshi Imamura, Shin-ichi Taniguchi, Kazuhiro Yamamoto
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 14, Iss 1, Pp 1-6 (2022)
Abstract Background Dipeptidyl peptidase 4 inhibitor (DPP4i) is an effective medicine for type 2 diabetes mellitus (T2DM). Some articles reported DPP4i improves insulin secretion and insulin resistance. However, these effects are not well established
Externí odkaz:
https://doaj.org/article/3bc35e08618a46a9b79bd2abf5fded01
Autor:
Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Sonoko Kitao, Yuichi Ito, Mari Anno, Kazuhisa Matsumoto, Kyoko Shoji, Kazuhiko Matsuzawa, Shoichiro Izawa, Hiroko Okura, Etsuko Ueta, Masahiko Kato, Takeshi Imamura, Shin-ichi Taniguchi, Kazuhiro Yamamoto
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Sodium–glucose cotransporter 2 inhibitor (SGLT2i) treatment is a therapeutic approach for type 2 diabetes mellitus (T2DM). Some reports have shown that SGLT2i treatment improves insulin resistance; however, few studies have evaluated insul
Externí odkaz:
https://doaj.org/article/40e6eae42092453980115d1f726a0d71
Autor:
Tsuyoshi Okura, Risa Nakamura, Mari Anno, Yuichi Ito, Sonoko Kitao, Kazuhisa Matsumoto, Kyoko Shoji, Kazuhiko Matsuzawa, Shoichiro Izawa, Hiroko Okura, Etsuko Ueta, Masahiko Kato, Takeshi Imamura, Shin-Ichi Taniguchi, Kazuhiro Yamamoto, Satomi Endo, Natsuka Taneda
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 10, Iss 5 (2022)
Introduction Pancreatic and duodenal homeobox factor-1 (PDX-1) is an imperative gene for insulin secretion in maturity-onset diabetes of the young 4. PDX-1 gene polymorphism was associated with lower first-phase insulin secretion in a genome-wide ass
Externí odkaz:
https://doaj.org/article/84fd26e982664409999ccb4251f4b1ca
Autor:
Hisashi Noma, Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Mari Anno, Yuichi Ito, Sonoko Kitao, Kazuhisa Matsumoto, Kyoko Shoji, Keisuke Sumi, Kazuhiko Matsuzawa, Shoichiro Izawa, Hiroko Okura, Etsuko Ueta, Masahiko Kato, Takeshi Imamura, Shin-Ichi Taniguchi, Kazuhiro Yamamoto
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
Introduction Hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes. HIC was reported to decrease in patients with type 2 diabetes and metabolic syndrome. However, hyperglycemia was suggested to enhance HIC, and it is not
Externí odkaz:
https://doaj.org/article/25ae4404afab4fd5a3d99eab60086ab1
Autor:
Mari Anno, Shoichiro Izawa, Yohei Fujioka, Kazuhiko Matsuzawa, Kohei Saito, Katsuya Hikita, Karen Makishima, Kanae Nosaka, Atsushi Takenaka, Takeshi Usui, Kazuhiro Yamamoto
Publikováno v:
Endocrine journal. 69(9)
Von Hippel-Lindau (VHL) disease is an autosomal dominant disease related to germline mutations in VHL. In VHL disease, pheochromocytoma develops in 10%-20% of patients because of germline mutations and loss of heterozygosity of VHL. However, the rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f0a2920bf44c237a37416dfcd4aa0cf
https://pubmed.ncbi.nlm.nih.gov/35466127
https://pubmed.ncbi.nlm.nih.gov/35466127
Autor:
Sonoko Kitao, Tsuyoshi Okura, Shin-ichi Taniguchi, Takeshi Imamura, Kazuhisa Matsumoto, Yohei Fujioka, Risa Nakamura, Shoichiro Izawa, Yuichi Ito, Etsuko Ueta, Kyoko Shoji, Kazuhiro Yamamoto, Masahiko Kato, Mari Anno, Kazuhiko Matsuzawa, Hiroko Okura
Introduction: Sodium-glucose cotransporter 2 inhibitor (SGLT2i) is a medication for type 2 diabetes mellitus (T2DM). Some reports showed SGLT2i improved insulin resistance, however, the effect on insulin resistance is not well established. Hepatic in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2ec60f619661b0ddab57f2cf03e58a6
https://doi.org/10.21203/rs.3.rs-882630/v1
https://doi.org/10.21203/rs.3.rs-882630/v1
Publikováno v:
Diabetes. 67
Aims: The hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes mellitus (T2DM). Some studies reported that HIC was decreased in the patients with T2DM. However, a basic research reported that hyperglycemia enhances HIC,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a8971a5515a1023913d4689e270eff9
https://doi.org/10.2337/db18-1946-p
https://doi.org/10.2337/db18-1946-p